Background
In December 2019, a series of mystical pneumonia cases appeared and soon
followed by an outbreak in Wuhan China, with clinical manifestations
similar to those of viral pneumonia 1. It was soon
discovered that this virus outbreak was due to a novel coronavirus which
is now named as severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) 2. At present, this novel coronavirus
caused disease (COVID-19) has spread throughout China and is rapidly
sweeping through countries all over the world 3-5.
Human-to-human transmission of this virus is clearly proven6,7. The clinical presentation of COVID-19 pneumonia
can be very diversified, and in severe cases it could
present as acute respiratory
distress syndrome (ARDS) that is often followed by death8-11.